Literature DB >> 25580864

Characterization of gene mutations and phenotypes of cystic fibrosis in Chinese patients.

Yaping Liu1, Lianqing Wang, Xinlun Tian, Kai-Feng Xu, Wenbing Xu, Xue Li, Cai Yue, Peng Zhang, Yi Xiao, Xue Zhang.   

Abstract

BACKGROUND AND
OBJECTIVE: Cystic fibrosis (CF) is a relatively common autosomal recessive disorder in Caucasians. CF is considered a very rare disease in Asians, and fewer than 30 Chinese CF patients are reported in the literature. We enrolled seven patients of Chinese Han origin diagnosed with CF at the Peking Union Medical College Hospital, to characterize gene mutations and phenotypes of CF in Chinese patients.
METHODS: We analysed the clinical presentation and screened the coding region of the CFTR gene for each patient.
RESULTS: Patients were 0-6 years old at onset of symptoms and were 10-28 years old at the time of diagnosis with CF. None of the seven patients had a family history of CF, and only one patient had parents who were consanguineous. Two patients had gastrointestinal symptoms but stool Sudan III results were normal. Four of the seven CF patients also had allergic bronchopulmonary aspergillosis. The concentration of chloride in patients' sweat ranged from 66 mmol/l to 154 mmol/l. In total, we identified 11 different mutations in seven CF patients, including one novel mutation (△E7-E11). Only one of these mutations (R553X) is present in the Caucasian CFTR common mutation-screening panel; and none of the 11 mutations are common in Caucasian CF patients.
CONCLUSIONS: CF in China is difficult to diagnose because of a combination of low awareness, atypical clinical symptoms, and a lack of sweat and genetic testing facilities in most hospitals. The mutations identified in Chinese CF patients are different from the common Caucasian gene mutations.
© 2015 Asian Pacific Society of Respirology.

Entities:  

Keywords:  CFTR; Chinese; cystic fibrosis; mutation; phenotype

Mesh:

Substances:

Year:  2015        PMID: 25580864     DOI: 10.1111/resp.12452

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  15 in total

1.  A novel homozygous complex deletion in CFTR caused cystic fibrosis in a Chinese patient.

Authors:  Keqiang Liu; Yaping Liu; Xue Li; Kai-Feng Xu; Xinlun Tian; Xue Zhang
Journal:  Mol Genet Genomics       Date:  2017-06-15       Impact factor: 3.291

2.  Mortality association of nontuberculous mycobacterial infection requiring treatment in Taiwan: a population-based study.

Authors:  Hsin-Hua Chen; Ching-Heng Lin; Wen-Cheng Chao
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 5.158

3.  p.G970D is the most frequent CFTR mutation in Chinese patients with cystic fibrosis.

Authors:  Xinlun Tian; Yaping Liu; Jun Yang; Han Wang; Tao Liu; Wenbing Xu; Xue Li; Yuanjue Zhu; Kai-Feng Xu; Xue Zhang
Journal:  Hum Genome Var       Date:  2016-01-07

4.  Differences in gene mutations between Chinese and Caucasian cystic fibrosis patients.

Authors:  Baoying Zheng; Ling Cao
Journal:  Pediatr Pulmonol       Date:  2016-10-07

5.  CFTR founder mutation causes protein trafficking defects in Chinese patients with cystic fibrosis.

Authors:  Gordon K C Leung; Dingge Ying; Christopher C Y Mak; Xin-Ying Chen; Weiyi Xu; Kit-San Yeung; Wai-Lap Wong; Yoyo W Y Chu; Gary T K Mok; Christy S K Chau; Jenna McLuskey; Winnie P T Ong; Huey-Yin Leong; Kelvin Y K Chan; Wanling Yang; Jeng-Haur Chen; Albert M Li; Pak C Sham; Yu-Lung Lau; Brian H Y Chung; So-Lun Lee
Journal:  Mol Genet Genomic Med       Date:  2016-11-13       Impact factor: 2.183

6.  Identification of a Mutation in the Novel Compound Heterozygous CFTR in a Chinese Family with Cystic Fibrosis.

Authors:  Hongxia Shao; Jingna Hua; Qi Wu; Xiaoge Li; Ming Zhang; Herong Wang; Junping Wu; Long Xu; Yi Xie; Li Li; Huaiyong Chen
Journal:  Can Respir J       Date:  2020-05-07       Impact factor: 2.409

7.  Next-generation sequencing for identifying genetic mutations in adults with bronchiectasis.

Authors:  Wei-Jie Guan; Jia-Cheng Li; Fang Liu; Jian Zhou; Ya-Ping Liu; Chao Ling; Yong-Hua Gao; Hui-Min Li; Jing-Jing Yuan; Yan Huang; Chun-Lan Chen; Rong-Chang Chen; Xue Zhang; Nan-Shan Zhong
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

8.  Impacts of Co-Existing Chronic Rhinosinusitis on Disease Severity and Risks of Exacerbations in Chinese Adults with Bronchiectasis.

Authors:  Wei-jie Guan; Yong-hua Gao; Hui-min Li; Jing-jing Yuan; Rong-chang Chen; Nan-shan Zhong
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

9.  Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study.

Authors:  Ping Wei; Jia-Wei Yang; Hai-Wen Lu; Bei Mao; Wen-Lan Yang; Jin-Fu Xu
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

10.  Characterization of clinical and genetic spectrum of Chinese patients with cystic fibrosis.

Authors:  Keqiang Liu; Wenshuai Xu; Meng Xiao; Xinyue Zhao; Chun Bian; Qianli Zhang; Jiaxing Song; Keqi Chen; Xinlun Tian; Yaping Liu; Kai-Feng Xu; Xue Zhang
Journal:  Orphanet J Rare Dis       Date:  2020-06-15       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.